NZ734801A - Fermented tea product - Google Patents

Fermented tea product

Info

Publication number
NZ734801A
NZ734801A NZ734801A NZ73480116A NZ734801A NZ 734801 A NZ734801 A NZ 734801A NZ 734801 A NZ734801 A NZ 734801A NZ 73480116 A NZ73480116 A NZ 73480116A NZ 734801 A NZ734801 A NZ 734801A
Authority
NZ
New Zealand
Prior art keywords
trihydroxyphenyl
composition
propan
body temperature
obesity
Prior art date
Application number
NZ734801A
Inventor
Yuko Yoshimoto
Eiji Fukushima
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of NZ734801A publication Critical patent/NZ734801A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065Diphenyl-substituted acyclic alcohols

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

The present invention provides the use of 1-(3’,4’,5’-trihydroxyphenyl)-3-(2’’,4’’,6’’-trihydroxyphenyl)-propan-2-ol in the manufacture of a composition for enhancing energy metabolism, enhancing sympathetic nerve activity promoting lipid combustion elevating body temperature or preventing or treating obesity. Also provided is a method for producing a 1-(3’,4’,5’-trihydroxyphenyl)-3-(2’’,4’’,6’’-trihydroxyphenyl)-propan-2-ol-containing composition, the method comprising fermenting a tea extract with a bacterium belonging to the genus Lactobacillus pentosus. The composition of the invention can be expected to have an effect of, for example, body temperature elevation, improvement in sensitivity to cold, anti-obesity, visceral fat loss, in-shape beauty, increase in metabolism, immunopotentiation, anti-fatigue, or anti-depression, or the like.
NZ734801A 2015-03-09 2016-03-07 Fermented tea product NZ734801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015046416 2015-03-09
JP2015046415 2015-03-09
PCT/JP2016/057009 WO2016143745A1 (en) 2015-03-09 2016-03-07 Fermented tea product

Publications (1)

Publication Number Publication Date
NZ734801A true NZ734801A (en) 2019-06-28

Family

ID=56880159

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ734801A NZ734801A (en) 2015-03-09 2016-03-07 Fermented tea product

Country Status (6)

Country Link
JP (2) JP6412248B2 (en)
AU (1) AU2016230139B2 (en)
MY (1) MY184881A (en)
NZ (1) NZ734801A (en)
TW (1) TWI681719B (en)
WO (1) WO2016143745A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6886571B2 (en) * 2016-09-21 2021-06-16 池田食研株式会社 Method for producing 4-ethylphenol
JP2018087171A (en) * 2016-11-29 2018-06-07 株式会社明治 Sympathetic nerve activating composition
JP6785141B2 (en) * 2016-12-09 2020-11-18 サントリーホールディングス株式会社 Basal metabolic rate enhancer
JP2021180619A (en) * 2020-05-18 2021-11-25 国立大学法人千葉大学 Fermented tea composition for controlling intestinal function and method of producing the same
JP2021020944A (en) * 2020-10-26 2021-02-18 サントリーホールディングス株式会社 Basal metabolism enhancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5568276B2 (en) * 2009-10-21 2014-08-06 三井農林株式会社 Method for producing catechin metabolites

Also Published As

Publication number Publication date
JPWO2016143745A1 (en) 2017-12-28
WO2016143745A1 (en) 2016-09-15
JP6669829B2 (en) 2020-03-18
MY184881A (en) 2021-04-29
AU2016230139B2 (en) 2018-10-18
TWI681719B (en) 2020-01-11
TW201642753A (en) 2016-12-16
JP2019011353A (en) 2019-01-24
AU2016230139A1 (en) 2017-09-21
JP6412248B2 (en) 2018-10-24

Similar Documents

Publication Publication Date Title
NZ734801A (en) Fermented tea product
PH12020500169A1 (en) Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
MX2022005890A (en) Methods for improving milk production by administration of microbial consortia.
MX357994B (en) COMPOSITIONS and METHODS OF USE FOR TREATING METABOLIC DISORDERS.
EA202091549A1 (en) PLANT-BASED PRODUCT AND PRODUCTION METHOD
MY173162A (en) Immune balance regulator
BR112015024330A2 (en) new lactic acid bacteria, medicine, food or drink, and feed containing the new lactic acid bacteria
WO2019066577A3 (en) Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
EP3943092A3 (en) Compositions for use in inducing differentiation of human brown adipocyte progenitors
MY172601A (en) Improved process for preparing fermented soybean meal
MX2015011861A (en) Bran and germ flavor and texture improvement.
MX2017005342A (en) Enzymes for malting.
JP2019011353A5 (en)
MY174654A (en) Method for preparing natural beef flavor
MY182351A (en) Manufacturing method of oil-and-fat for enhancing salty taste
PH12020551910A1 (en) Sugar cane extracts for use in animal feeds
PH12017501725A1 (en) Tien-cha extract essence and application therefor
MY176017A (en) Method for producing fermented bamboo extract and immunostimulating agent
MX2015012205A (en) High fat human milk products.
MX2017001632A (en) Myo-inositol and probiotics, and their use.
BR112014004123A2 (en) microorganisms of the xylanisolvens bacteroid species
MX358002B (en) Magnetic polyurethane composition for nerve stimulation.
SG11201809402VA (en) Technology for efficient activation of nkt cells
PH12015502623A1 (en) Composition and nutritional products with improved emulsion stability

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2021 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20200107

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2022 BY CPA GLOBAL

Effective date: 20210128

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 07 MAR 2023 BY CPA GLOBAL

Effective date: 20220127

LAPS Patent lapsed